Horn Patrick Taylor 4
4 · ALBIREO PHARMA, INC. · Filed Apr 26, 2021
Insider Transaction Report
Form 4
Horn Patrick Taylor
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-04-22$31.75/sh−90$2,858→ 11,893 total
Footnotes (2)
- [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
- [F2]Represents 4,205 shares of common stock and 7,688 restricted stock units. Includes 940 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2019, 13 shares of common stock acquired under the ESPP on November 30, 2019, and 1,205 shares of common stock acquired under the ESPP on May 31, 2020.